Development and validation of a nomogram for predicting the risk of vasovagal reactions after plasma donation

被引:1
|
作者
Zhao, Peizhe [1 ,2 ,3 ]
Dong, Demei [4 ]
Dong, Rong [5 ]
Zhou, Yuan [1 ]
Hong, Yan [6 ]
Xiao, Guanglin [2 ]
Li, Zhiye [1 ]
Su, Xuelin [5 ]
Zheng, Xingyou [5 ]
Liu, Xia [5 ]
Zhang, Demei [1 ,8 ]
Li, Ling [7 ]
Liu, Zhong [2 ,3 ]
机构
[1] Taiyuan Blood Ctr, Dept Blood Transfus, Taiyuan, Shanxi, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China
[3] CAMS, Key Lab Transfus Adverse React, Chengdu, Sichuan, Peoples R China
[4] Beijing Tiantan Biol Prod Co Ltd, Dept Qual Control, Beijing, Peoples R China
[5] Jianyang Rongsheng Apheresis Plasma Co Ltd, Dept Plasma Apheresis, Jianyang, Sichuan, Peoples R China
[6] Shifang Rongsheng Apheresis Plasma Co Ltd, Dept Plasma Apheresis, Shifang, Sichuan, Peoples R China
[7] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Blood Transfus, Affiliated Hosp, Chengdu, Sichuan, Peoples R China
[8] Taiyuan Blood Ctr, Dept Blood Transfus, 185 Yingze West St, Taiyuan, Shanxi, Peoples R China
关键词
donor health; nomogram; plasma donation; prediction model; vasovagal reaction; BLOOD-DONATION; MULTICENTER; DONORS; CANCER; SAFETY; FEAR;
D O I
10.1002/jca.22074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Vasovagal reactions (VVRs) are the most common adverse reactions and are frequently associated with serious donor adverse events. Even mild VVRs can lead to a significant reduction in the likelihood of subsequent donations. The purpose of this study is to explore the factors related to the occurrence of VVRs after plasma donation and to construct a nomogram to identify individuals at risk for VVRs to improve the safety of plasma donors.Materials and Methods: We collected the donation data from July 2019 to June 2020 from a plasma center in Sichuan, China, to explore the independent risk factors for vasovagal reactions. From these data, we constructed and validated a predictive model for vasovagal reactions.Results: VVRs after plasma donation occurred 737 times in 120 448 plasma donations (0.66%). Gender, season, donor status, weight, pulse, duration of donation, and cycle were independent risk factors for VVRs (P< 0.05). The concordance index (C-index) of a logistic model in the derivation cohort was 0.916, with a Hosmer-Lemeshow goodness-of-fit probability of 0.795. The C-index of a logistic model in the validation cohort was 0.916, with a Hosmer-Lemeshow goodness-of-fit probability of 0.224. The calibration curve showed that the predicted results were in good agreement with the actual observed results.Conclusion: This study preliminarily constructed and verified a prediction model for VVRs after plasma donation. The model nomogram is practical and can identify high-risk donors.
引用
收藏
页码:622 / 631
页数:10
相关论文
共 50 条
  • [31] The Development and Validation of a Nomogram for Predicting Sepsis Risk in Diabetic Patients with Urinary Tract Infection
    Tan, Hua-Qiao
    Duan, Xiang-Jie
    Qu, Wan
    Shu, Mi
    Zhong, Guang-Yao
    Liang, Li-Hong
    Bin, Dong-Mei
    Chen, Yu-Ming
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [32] Predicting the risk of active pulmonary tuberculosis in people living with HIV: development and validation of a nomogram
    Jinou Chen
    Ling Li
    Tao Chen
    Xing Yang
    Haohao Ru
    Xia Li
    Xinping Yang
    Qi Xie
    Lin Xu
    BMC Infectious Diseases, 22
  • [33] Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection
    Cai, Tommaso
    Mazzoli, Sandra
    Migno, Serena
    Malossini, Gianni
    Lanzafame, Paolo
    Mereu, Liliana
    Tateo, Saverio
    Wagenlehner, Florian M. E.
    Pickard, Robert S.
    Bartoletti, Riccardo
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (09) : 929 - 934
  • [34] Predicting the risk of active pulmonary tuberculosis in people living with HIV: development and validation of a nomogram
    Chen, Jinou
    Li, Ling
    Chen, Tao
    Yang, Xing
    Ru, Haohao
    Li, Xia
    Yang, Xinping
    Xie, Qi
    Xu, Lin
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [35] A nomogram for predicting the risk of femoral pseudoaneurysm after neurointerventional procedures
    Yang, Liangliang
    Zhao, Puyuan
    Liu, Bin
    Gao, Yang
    Zhou, Hao
    Li, Qiuping
    Jiang, Yingchuan
    Yang, Zhigang
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
  • [36] Development and validation of nomogram for predicting early recurrence after radical gastrectomy of gastric cancer
    Mengxuan Cao
    Can Hu
    Siwei Pan
    Yanqiang Zhang
    Pengcheng Yu
    Ruolan Zhang
    Xiangdong Cheng
    Zhiyuan Xu
    World Journal of Surgical Oncology, 22
  • [37] Development and Validation of an Individualized Nomogram for Predicting Survival in Patients with Esophageal Carcinoma after Resection
    Du, Feng
    Sun, Zhiwei
    Jia, Jun
    Yang, Ying
    Yu, Jing
    Shi, Youwu
    Jia, Bo
    Zhao, Jiuda
    Zhang, Xiaodong
    JOURNAL OF CANCER, 2020, 11 (14): : 4023 - 4029
  • [38] Development and validation of a nomogram to predict anastomotic leakage after esophagectomy for esophageal carcinoma
    Yu, Wen-Quan
    Gao, Hui-Jiang
    Shi, Guo-Dong
    Tang, Jia-Yu
    Wang, Hua-Feng
    Hu, Shi-Yu
    Wei, Yu-Cheng
    JOURNAL OF THORACIC DISEASE, 2021, 13 (06) : 3549 - 3565
  • [39] Development and validation of nomogram for predicting early recurrence after radical gastrectomy of gastric cancer
    Cao, Mengxuan
    Hu, Can
    Pan, Siwei
    Zhang, Yanqiang
    Yu, Pengcheng
    Zhang, Ruolan
    Cheng, Xiangdong
    Xu, Zhiyuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [40] Development and validation of a nomogram for predicting the risk of developing gastric cancer based on a questionnaire: a cross-sectional study
    Huang, Zhangsen
    Chen, Songyao
    Yin, Songcheng
    Shi, Zhaowen
    Gu, Liang
    Li, Liang
    Yin, Haofan
    Huang, Zhijian
    Li, Bo
    Chen, Xin
    Yang, Yilin
    Wang, Zhengli
    Li, Hai
    Zhang, Changhua
    He, Yulong
    FRONTIERS IN ONCOLOGY, 2024, 14